In summary, reduced hepatic mitochondrial content and function and an upregulation in de novo lipogenesis contribute to obesity-associated NAFLD in the leptin-deficient Ob/Ob mouse. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.